Sprint Bioscience AB banner
S

Sprint Bioscience AB
XMUN:5JA1

Watchlist Manager
Sprint Bioscience AB
XMUN:5JA1
Watchlist
Price: 0.271 EUR -3.21% Market Closed
Market Cap: €54.7m

Wall St Price Targets

5JA1 Price Targets Summary
Sprint Bioscience AB

Wall Street analysts forecast 5JA1 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 5JA1 is 0.484 EUR with a low forecast of 0.479 EUR and a high forecast of 0.498 EUR.

Lowest Forecast
Price Target
0.479 EUR
77% Upside
Average Forecast
Price Target
0.484 EUR
79% Upside
Highest Forecast
Price Target
0.498 EUR
84% Upside
Sprint Bioscience AB Competitors:
Price Targets
BTBT
Bit Digital Inc
223% Upside
3363
FOCI Fiber Optic Communications Inc
1% Upside
ENVX
Enovix Corp
269% Upside
PTCT
PTC Therapeutics Inc
53% Upside
PTEN
Patterson-UTI Energy Inc
11% Upside

Revenue
Forecast

43% / Year
Past Growth
-19% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
43% / Year
Past Growth
-19% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 12 years, the compound annual growth rate for Revenue has been 43%. The projected CAGR for the next 3 years is -19%.

Gross Profit
Forecast

31% / Year
Past Growth
-24% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
31% / Year
Past Growth
-24% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 12 years, the compound annual growth rate for Gross Profit has been 31%. The projected CAGR for the next 2 years is -24%.

Operating Income
Forecast

N/A
Past Growth
-73% / Year
Estimated Growth
Estimates Accuracy
15%
Average Beat
N/A
Past Growth
-73% / Year
Estimated Growth
Estimates Accuracy
15%
Average Beat

The compound annual growth rate for Operating Income over the next 3 years is -73%.

Pre-Tax Income
Forecast

N/A
Past Growth
-20% / Year
Estimated Growth
Estimates Accuracy
31%
Average Beat
N/A
Past Growth
-20% / Year
Estimated Growth
Estimates Accuracy
31%
Average Beat

The compound annual growth rate for Pre-Tax Income over the next 2 years is -20%.

Net Income
Forecast

N/A
Past Growth
-15% / Year
Estimated Growth
Estimates Accuracy
26%
Average Beat
N/A
Past Growth
-15% / Year
Estimated Growth
Estimates Accuracy
26%
Average Beat

The compound annual growth rate for Net Income over the next 2 years is -15%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 5JA1's stock price target?
Price Target
0.484 EUR

According to Wall Street analysts, the average 1-year price target for 5JA1 is 0.484 EUR with a low forecast of 0.479 EUR and a high forecast of 0.498 EUR.

What is the Revenue forecast for Sprint Bioscience AB?
Projected CAGR
-19%

Over the last 12 years, the compound annual growth rate for Revenue has been 43%. The projected CAGR for the next 3 years is -19%.

What is the Gross Profit forecast for Sprint Bioscience AB?
Projected CAGR
-24%

Over the last 12 years, the compound annual growth rate for Gross Profit has been 31%. The projected CAGR for the next 2 years is -24%.

What is the Operating Income forecast for Sprint Bioscience AB?
Projected CAGR
-73%

The compound annual growth rate for Operating Income over the next 3 years is -73%.

What is the Pre-Tax Income forecast for Sprint Bioscience AB?
Projected CAGR
-20%

The compound annual growth rate for Pre-Tax Income over the next 2 years is -20%.

What is the Net Income forecast for Sprint Bioscience AB?
Projected CAGR
-15%

The compound annual growth rate for Net Income over the next 2 years is -15%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett